PRAX-114

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePRAX-114
Drug Alias NamePRAX-114
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor modulators
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsStress Disorders, Post-TraumaticTrauma and Stressor Related DisordersDepressive Disorder, Major +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPraxis Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesPraxis Precision Medicines
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Major
Inactive IndicationsStress Disorders, Post-TraumaticTrauma and Stressor Related DisordersMental Disorders +[4] 

Other Information

ATC CodeN/A
Related LinksN/A